The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Travel, Accommodations, Expenses - Oncoceutics
Anticancer and immunostimulatory activity of the imipridone ONC201, a selective DRD2 antagonist, in advanced cancer patients.
 
Mark N. Stein
Research Funding - Abbvie (Inst); Advaxis (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Janssen Oncology (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Oncoceutics (Inst)
 
Nancy Chan
No Relationships to Disclose
 
Ann W. Silk
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Prometheus (Inst)
 
Jyoti Malhotra
No Relationships to Disclose
 
Joseph Aisner
Honoraria - Ethicon
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono
 
Robert Aiken
No Relationships to Disclose
 
Andrew Zloza
No Relationships to Disclose
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Oncoceutics; p53-Therapeutics
Research Funding - Morphotek
Patents, Royalties, Other Intellectual Property - I hold patents and have submitted patents relevant to my academic laboratory research. However, these patent have no relationship with my GI ASCO presentation.
Other Relationship - Caris Life Sciences
 
Jenna Newman
No Relationships to Disclose
 
Charles Chesson
No Relationships to Disclose
 
Rohinton Tarapore
No Relationships to Disclose
 
Joshua E. Allen
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
Travel, Accommodations, Expenses - Oncoceutics
 
Wolfgang Oster
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Travel, Accommodations, Expenses - Oncoceutics
 
Tracie Saunders
No Relationships to Disclose
 
Bangning Yu
No Relationships to Disclose
 
Siobhan Dickerson
No Relationships to Disclose
 
Lorna Rodriguez-Rodriguez
No Relationships to Disclose
 
Bruce George Haffty
No Relationships to Disclose
 
Howard Kaufman
Employment - Compass Therapeutics
Leadership - Compass Therapeutics
Honoraria - Amgen; Celldex; Compass Therapeutics; EMD Serono; Merck; Prometheus; Turnstone Bio
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celldex; Compass Therapeutics; Merck; Merck Serono; Prometheus; Turnstone Bio
Speakers' Bureau - Merck
Research Funding - Amgen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - EMD Serono; Turnstone Bio
 
Janice M. Mehnert
Honoraria - EMD Serono; Genentech
Consulting or Advisory Role - Amgen; Merck Sharp & Dohme
Research Funding - Amgen (Inst); AstraZeneca (Inst); Immunocore (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - EMD Serono; Merck Sharp & Dohme
Other Relationship - Amgen; EMD Serono; Merck; Merck